The World Health Organisation (WHO) has said that additional clarifications from manufacturer are needed to conduct a final Emergency Use Listing (EUL) risk-benefit assessment for global use of India-made COVAXIN.
“Technical Advisory Group (TAG) for Emergency Use Listing has decided that additional clarifications from the manufacturer are needed to conduct a final EUL risk-benefit assessment for global use of the vaccine,” the WHO said.
The Australian Open is streaming animated versions of tennis matches, like Alexander Zverev's second-round match,…
The PCB is confident India’s captain Rohit Sharma will attend Champions Trophy 2025 events despite…
A viral video from @foodsafetywar claims unhygienic practices at Amritsar Haveli, Hyderabad, showing reused leftover…
The PCB has set Champions Trophy ticket prices starting at PKR 1000, with variations for…
Nathan Anderson shuts down Hindenburg Research, citing burnout. Analysts question the fate of ongoing cases…
ISRO successfully docked its SpaDeX satellites, making India the fourth country to achieve in-space docking.…